BREWIN DOLPHIN LTD - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 8 filers reported holding KAZIA THERAPEUTICS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2021$362
+14.6%
320.0%0.00%
Q2 2021$316
-20.4%
320.0%0.00%
Q1 2021$397
+43.8%
320.0%0.00%
Q4 2020$276
+27.8%
320.0%0.00%
Q3 2020$216
+100.0%
320.0%0.00%
Q2 2020$108
+16.1%
320.0%0.00%
Q1 2020$93
-33.1%
320.0%0.00%
Q4 2019$139
+15.8%
320.0%0.00%
Q3 2019$120
+44.6%
320.0%0.00%
Q2 2019$83
-22.4%
320.0%0.00%
Q1 2019$107
+37.2%
320.0%0.00%
Q4 2018$78
-23.5%
320.0%0.00%
Q3 2018$102
+7.4%
320.0%0.00%
Q2 2018$95
-47.2%
320.0%0.00%
Q1 2018$180320.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Transform Wealth, LLC 106,245$35,0000.01%
UBS Group AG 1,546$5,0000.00%
Renaissance Technologies 34,325$115,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BREWIN DOLPHIN LTD 32$1070.00%
MORGAN STANLEY 63,017$210,0000.00%
AdvisorNet Financial, Inc 5$00.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders